Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP616203.RAsRSX3FriTfeoZXeb_V9mKFuCFRmJyHAeR_Em1eynb5M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP616203.RAsRSX3FriTfeoZXeb_V9mKFuCFRmJyHAeR_Em1eynb5M130_assertion type Assertion NP616203.RAsRSX3FriTfeoZXeb_V9mKFuCFRmJyHAeR_Em1eynb5M130_head.
- NP616203.RAsRSX3FriTfeoZXeb_V9mKFuCFRmJyHAeR_Em1eynb5M130_assertion description "[Acetyl-L-carnitine (ALC) has gained clinical interest for its analgesic effect in different forms of neuropathies associated with chronic pain, such as diabetic and HIV-related peripheral neuropathies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616203.RAsRSX3FriTfeoZXeb_V9mKFuCFRmJyHAeR_Em1eynb5M130_provenance.
- NP616203.RAsRSX3FriTfeoZXeb_V9mKFuCFRmJyHAeR_Em1eynb5M130_assertion evidence source_evidence_literature NP616203.RAsRSX3FriTfeoZXeb_V9mKFuCFRmJyHAeR_Em1eynb5M130_provenance.
- NP616203.RAsRSX3FriTfeoZXeb_V9mKFuCFRmJyHAeR_Em1eynb5M130_assertion SIO_000772 17696591 NP616203.RAsRSX3FriTfeoZXeb_V9mKFuCFRmJyHAeR_Em1eynb5M130_provenance.
- NP616203.RAsRSX3FriTfeoZXeb_V9mKFuCFRmJyHAeR_Em1eynb5M130_assertion wasDerivedFrom befree-20140225 NP616203.RAsRSX3FriTfeoZXeb_V9mKFuCFRmJyHAeR_Em1eynb5M130_provenance.
- NP616203.RAsRSX3FriTfeoZXeb_V9mKFuCFRmJyHAeR_Em1eynb5M130_assertion wasGeneratedBy ECO_0000203 NP616203.RAsRSX3FriTfeoZXeb_V9mKFuCFRmJyHAeR_Em1eynb5M130_provenance.